BeyondSpring

BeyondSpring is laying off 35% of staff in wake of FDA rejection of lead drug
MedCity News
Thu, 01/13/22 - 07:18 am
BeyondSpring
FDA
layoffs
plinabulin
FDA turns down BeyondSpring chemo complication drug, asks for another trial
Fierce Pharma
Wed, 12/1/21 - 11:48 pm
BeyondSpring
FDA
small molecule drugs
plinabulin
3 Biotech Stocks With Huge Catalysts Incoming
Motley Fool
Fri, 10/22/21 - 11:19 am
BeyondSpring
Allakos
Deciphera
plinabulin
lirentelimab
Qinlock
Plinabulin blooms at last for Beyondspring
EP Vantage
Thu, 08/5/21 - 10:43 am
BeyondSpring
clinical trials
plinabulin
vascular disrupting agents
Second-quarter catalysts for the smaller players
EP Vantage
Wed, 04/7/21 - 10:25 am
AC Immune
Anavex
Santhera
IMMUTEP
Syndax
Novan
Fulcrum Therapeutics
BeyondSpring
Corbus
Orphazyme
Aldeyra
Adaptimmune
Inflarx
Sutro
Gemini Therapeutics
20,000 leagues for biotech to explore
BioPharma Dive
Mon, 03/27/17 - 10:31 am
biotech
bioprospecting
PharmaMar
BeyondSpring
Ohr Pharmaceutical
Wex Pharmaceuticals